172 related articles for article (PubMed ID: 9584851)
21. Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy.
Hardt PD; Ewald N
Expert Rev Mol Diagn; 2008 Sep; 8(5):579-85. PubMed ID: 18785806
[TBL] [Abstract][Full Text] [Related]
22. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
Tamada M; Suematsu M; Saya H
Clin Cancer Res; 2012 Oct; 18(20):5554-61. PubMed ID: 23071357
[TBL] [Abstract][Full Text] [Related]
23. [Properties of pyruvate kinase isozyme from rat ascites hepatoma 13 cells].
Tachikawa A
Josai Shika Daigaku Kiyo; 1984; 13(1):1-17. PubMed ID: 6098325
[No Abstract] [Full Text] [Related]
24. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
Kumar Y; Tapuria N; Kirmani N; Davidson BR
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
[TBL] [Abstract][Full Text] [Related]
25. Different involvement for aldolase isoenzymes in kidney glucose metabolism: aldolase B but not aldolase A colocalizes and forms a complex with FBPase.
Yañez AJ; Ludwig HC; Bertinat R; Spichiger C; Gatica R; Berlien G; Leon O; Brito M; Concha II; Slebe JC
J Cell Physiol; 2005 Mar; 202(3):743-53. PubMed ID: 15389646
[TBL] [Abstract][Full Text] [Related]
26. Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation.
Spoden GA; Mazurek S; Morandell D; Bacher N; Ausserlechner MJ; Jansen-Dürr P; Eigenbrodt E; Zwerschke W
Int J Cancer; 2008 Jul; 123(2):312-321. PubMed ID: 18425820
[TBL] [Abstract][Full Text] [Related]
27. Pre-analytical problems in the measurement of tumor type pyruvate kinase (tumor M2-PK).
Oremek GM; Gerstmeier F; Sauer-Eppel H; Sapoutzis N; Wechsel HW
Anticancer Res; 2003; 23(2A):1127-30. PubMed ID: 12820359
[TBL] [Abstract][Full Text] [Related]
28. A pyruvate kinase variant in different mouse transplanted tumors.
Marchut E; Gumińska M; Kedryna T; Radzikowski C; Kuśnierczyk H
Experientia; 1988 Jan; 44(1):25-7. PubMed ID: 3350115
[TBL] [Abstract][Full Text] [Related]
29. Isozyme patterns of normal, benign, and malignant human breast tissues.
Balinsky D; Platz CE; Lewis JW
Cancer Res; 1983 Dec; 43(12 Pt 1):5895-901. PubMed ID: 6640538
[TBL] [Abstract][Full Text] [Related]
30. Pyruvate kinase activity in the placentas of women living in polluted and unpolluted environments.
Kedryna T; Gumińska M; Lucyna Z
Med Sci Monit; 2004 Dec; 10(12):CR672-8. PubMed ID: 15567985
[TBL] [Abstract][Full Text] [Related]
31. Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture.
Weinhouse S
Cancer Res; 1972 Oct; 32(10):2007-16. PubMed ID: 4343003
[No Abstract] [Full Text] [Related]
32. The dual activity of pyruvate kinase type M2 from chromatin extracts of neoplastic cells.
Ignacak J; Stachurska MB
Comp Biochem Physiol B Biochem Mol Biol; 2003 Mar; 134(3):425-33. PubMed ID: 12628374
[TBL] [Abstract][Full Text] [Related]
33. Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours.
Mazurek S
Ernst Schering Found Symp Proc; 2007; (4):99-124. PubMed ID: 18811055
[TBL] [Abstract][Full Text] [Related]
34. Pyruvate kinase inhibited by L-cysteine as a marker of tumorigenic human urothelial cell lines.
Gumińska M; Stachurska MB; Christensen B; Tromholt V; Kieler J; Radzikowski C; Duś D
Experientia; 1989 Jun; 45(6):571-4. PubMed ID: 2737264
[TBL] [Abstract][Full Text] [Related]
35. The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma.
Oremek GM; Teigelkamp S; Kramer W; Eigenbrodt E; Usadel KH
Anticancer Res; 1999; 19(4A):2599-601. PubMed ID: 10470201
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma.
Kaura B; Bagga R; Patel FD
J Obstet Gynaecol Res; 2004 Jun; 30(3):193-6. PubMed ID: 15210041
[TBL] [Abstract][Full Text] [Related]
37. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism.
Mazurek S; Drexler HC; Troppmair J; Eigenbrodt E; Rapp UR
Anticancer Res; 2007; 27(6B):3963-71. PubMed ID: 18225557
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis.
Dombrauckas JD; Santarsiero BD; Mesecar AD
Biochemistry; 2005 Jul; 44(27):9417-29. PubMed ID: 15996096
[TBL] [Abstract][Full Text] [Related]
39. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
[TBL] [Abstract][Full Text] [Related]
40. [Isoenzyme spectrum and kinetic properties of pyruvate kinase from the liver of thiamine-deficient rats].
Konovalenko OV; Maglysh SS; Gorbach ZV
Ukr Biokhim Zh (1978); 1990; 62(4):50-5. PubMed ID: 2238154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
